Clinical Trial Supply Chains Face Tariff Volatility Risks

Clinical trial supply chains are increasingly vulnerable to tariff-related disruptions, requiring proactive planning and mitigation strategies.

Organizations managing trial logistics must anticipate trade policy changes and develop contingency plans to maintain schedule adherence and cost predictability.

The intersection of trade policy uncertainty and the time-sensitive nature of clinical operations creates significant operational and financial risk.